XML 34 R13.htm IDEA: XBRL DOCUMENT v3.22.0.1
EPLP - Consolidated Statements of Capital - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Increase (Decrease) in Partners' Capital [Roll Forward]        
Net income $ 515,691 $ 599,332 $ 464,448  
Reversal of unrealized gains upon the sale of marketable securities 0 0 (32)  
Cash flow hedge losses reclassified to earnings 0 3,338 1,824  
Change in fair value of derivatives and amortization of swap settlements 9,170 (4,148) (2,948)  
Change in fair value of marketable securities, net 329 (61) 281  
Issuance of common stock under:        
Sale of common stock by general partner, net (455) (296) 72,539  
Retirement of common stock, net (9,172) (269,315) $ (56,989)  
Accounting Standards Update [Extensible List]     Accounting Standards Update 2016-13 [Member] Accounting Standards Update 2017-12 [Member]
Changes in the redemption value of redeemable noncontrolling interest (6,890) 4,299 $ (2,008)  
Changes in noncontrolling interest from acquisition   1,349 65,472  
Contributions from noncontrolling interest 1,900      
Distributions to noncontrolling interest (29,341) (31,367) (28,493)  
Redemptions (8,457) (3,113) (36,568)  
Essex Portfolio, L.P.        
Increase (Decrease) in Partners' Capital [Roll Forward]        
Balances 6,183,192 6,403,504 6,393,844  
Net income 515,691 599,332 464,448  
Reversal of unrealized gains upon the sale of marketable securities 0 0 (32)  
Cash flow hedge losses reclassified to earnings 0 3,338 1,824  
Change in fair value of derivatives and amortization of swap settlements 9,170 (4,148) (2,948)  
Change in fair value of marketable securities, net 329 (61) 281  
Issuance of common stock under:        
General partner's stock based compensation, net 53,052 9,201 33,779  
Sale of common stock by general partner, net (455) (296) 72,539  
Equity based compensation costs 11,683 12,913 12,283  
Retirement of common stock, net (9,172) (269,315) (56,989)  
Cumulative effect upon adoption 6,176,508 6,183,192 6,403,504 $ 6,393,844
Changes in the redemption value of redeemable noncontrolling interest (6,890) 4,299 (2,008)  
Changes in noncontrolling interest from acquisition   1,349 65,472  
Contributions from noncontrolling interest 1,900      
Distributions to noncontrolling interest (10,215) (12,292) (10,521)  
Redemptions (8,457) (3,113) (36,568)  
Distributions declared (563,320) (561,329) (532,081)  
Balances 6,176,508 6,183,192 6,403,504 6,393,844
Essex Portfolio, L.P. | Cumulative Effect, Period of Adoption, Adjustment        
Increase (Decrease) in Partners' Capital [Roll Forward]        
Balances   (190) 181  
Issuance of common stock under:        
Cumulative effect upon adoption     (190) 181
Balances     (190) 181
Essex Portfolio, L.P. | Accumulated other comprehensive loss, net        
Increase (Decrease) in Partners' Capital [Roll Forward]        
Balances (11,303) (10,432) (9,738)  
Reversal of unrealized gains upon the sale of marketable securities     (32)  
Cash flow hedge losses reclassified to earnings   3,338 1,824  
Change in fair value of derivatives and amortization of swap settlements 9,170 (4,148) (2,948)  
Change in fair value of marketable securities, net 329 (61) 281  
Issuance of common stock under:        
Cumulative effect upon adoption (1,804) (11,303) (10,432) (9,738)
Balances (1,804) (11,303) (10,432) (9,738)
Essex Portfolio, L.P. | Accumulated other comprehensive loss, net | Cumulative Effect, Period of Adoption, Adjustment        
Increase (Decrease) in Partners' Capital [Roll Forward]        
Balances     181  
Issuance of common stock under:        
Cumulative effect upon adoption       181
Balances       181
Essex Portfolio, L.P. | Noncontrolling interest        
Increase (Decrease) in Partners' Capital [Roll Forward]        
Balances 121,172 122,262 64,231  
Net income 9,946 10,550 9,819  
Issuance of common stock under:        
Cumulative effect upon adoption 122,655 121,172 122,262 64,231
Changes in the redemption value of redeemable noncontrolling interest 447 121 1,310  
Changes in noncontrolling interest from acquisition   1,349 65,472  
Contributions from noncontrolling interest 1,900      
Distributions to noncontrolling interest (10,215) (12,292) (10,521)  
Redemptions (595) (818) (8,049)  
Balances 122,655 121,172 122,262 64,231
Essex Portfolio, L.P. | General Partner | Common Equity        
Increase (Decrease) in Partners' Capital [Roll Forward]        
Balances $ 6,015,139 $ 6,234,315 $ 6,280,290  
Balances (in shares) 64,999 66,092 65,890  
Net income $ 488,554 $ 568,870 $ 439,286  
Issuance of common stock under:        
General partner's stock based compensation, net $ 53,052 $ 9,201 $ 33,779  
General partner's stock based compensation, net (in shares) 279 95 195  
Sale of common stock by general partner, net $ (455) $ (296) $ 72,539  
Sale of common stock by general partner, net (in shares)     228  
Equity based compensation costs 11,286 12,453 $ 11,029  
Retirement of common stock, net $ (9,172) $ (269,315) $ (56,989)  
Retirement of common stock, net (in shares) (40) (1,197) (234)  
Cumulative effect upon adoption $ 5,999,155 $ 6,015,139 $ 6,234,315 $ 6,280,290
Accounting Standards Update [Extensible List]     Accounting Standards Update 2016-13 [Member] Accounting Standards Update 2017-12 [Member]
Changes in the redemption value of redeemable noncontrolling interest (7,489) 4,375 $ (3,427)  
Redemptions $ (7,566) $ (2,020) $ (28,083)  
Redemptions (in shares) 10 9 13  
Distributions declared $ (544,194) $ (542,254) $ (514,109)  
Balances $ 5,999,155 $ 6,015,139 $ 6,234,315 $ 6,280,290
Balances (in shares) 65,248 64,999 66,092 65,890
Essex Portfolio, L.P. | General Partner | Common Equity | Cumulative Effect, Period of Adoption, Adjustment        
Increase (Decrease) in Partners' Capital [Roll Forward]        
Balances   $ (190)    
Issuance of common stock under:        
Cumulative effect upon adoption     $ (190)  
Balances     (190)  
Essex Portfolio, L.P. | Limited Partner | Common Equity        
Increase (Decrease) in Partners' Capital [Roll Forward]        
Balances $ 58,184 $ 57,359 $ 59,061  
Balances (in shares) 2,295 2,302 2,305  
Net income $ 17,191 $ 19,912 $ 15,343  
Issuance of common stock under:        
Equity based compensation costs 397 $ 460 $ 1,254  
Equity based compensation costs (in shares)   2 10  
Cumulative effect upon adoption 56,502 $ 58,184 $ 57,359 $ 59,061
Changes in the redemption value of redeemable noncontrolling interest 152 (197) 109  
Redemptions $ (296) $ (275) $ (436)  
Redemptions (in shares) (13) (9) (13)  
Distributions declared $ (19,126) $ (19,075) $ (17,972)  
Balances $ 56,502 $ 58,184 $ 57,359 $ 59,061
Balances (in shares) 2,282 2,295 2,302 2,305